PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE

被引：3
|
作者：
Chan, H. L. [1 ]
Ahn, S. H. [2 ]
Chang, T. -T. [3 ]
Peng, C. -Y. [4 ]
Wong, D. [5 ]
Coffin, C. S. [6 ]
Lim, S. G. [7 ]
Chen, P. -J. [8 ]
Janssen, H. L. [9 ,10 ]
Marcellin, P. [11 ]
Serfaty, L. [12 ]
Zeuzem, S. [13 ]
Cohen, D. [14 ]
Critelli, L. [14 ]
Xu, D. [14 ]
Cooney, E. [14 ]
机构：
[1] Chinese Univ Hong Kong, Div Gastroenterol & Hepatol, Shatin, Hong Kong, Peoples R China
[2] Yonsei Univ, Severance Hosp, Seoul 120749, South Korea
[3] Natl Chen Kung Univ Hosp, Tainan, Taiwan
[4] China Med Univ Hosp, Taichung, Taiwan
[5] Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada
[6] Univ Calgary, Div Gastroenterol & Hepatol, Liver Unit, Calgary, AB, Canada
[7] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[8] Natl Taiwan Univ Hosp, Taipei, Taiwan
[9] Erasmus MC, Rotterdam, Netherlands
[10] Univ Hlth Network, Toronto, ON, Canada
[11] Hop Beaujon, Clichy, France
[12] Hop St Antoine, F-75571 Paris, France
[13] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany
[14] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60117-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O115
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease
    Chan, Henry Lik-Yuen
    Ahn, Sang Hoon
    Chang, Ting-Tsung
    Peng, Cheng-Yuan
    Wong, David K.
    Coffin, Carla S.
    Lim, Seng Gee
    Chen, Pei-Jer
    Janssen, Harry L.
    Marcellin, Patrick
    Serfaty, Lawrence
    Zeuzem, Stefan
    Hu, Wenhua
    Critelli, Linda
    Lopez-Talavera, Juan Carlos
    Cooney, Elizabeth L.
    HEPATOLOGY, 2012, 56 (06) : 1525 - 1526
  • [2] ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB)
    Chan, H. L.
    Ahn, S. H.
    Chang, T. -T.
    Peng, C. -Y.
    Wong, D.
    Coffin, C.
    Lim, S. G.
    Chen, P. -J.
    Janssen, H. L.
    Marcellin, P.
    Serfaty, L.
    Zeuzem, S.
    Hu, W.
    Critelli, L.
    Wind-Rotolo, M.
    Srinivasan, S.
    Lopez-Talavera, J. C.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S300 - S300
  • [3] Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
    Chan, Henry L. Y.
    Ahn, Sang Hoon
    Chang, Ting-Tsung
    Peng, Cheng-Yuan
    Wong, David
    Coffin, Carla S.
    Lim, Seng Gee
    Chen, Pei-Jer
    Janssen, Harry L. A.
    Marcellin, Patrick
    Serfaty, Lawrence
    Zeuzem, Stefan
    Cohen, David
    Critelli, Linda
    Xu, Dong
    Wind-Rotolo, Megan
    Cooney, Elizabeth
    JOURNAL OF HEPATOLOGY, 2016, 64 (05) : 1011 - 1019
  • [4] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [5] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [6] Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine
    Song, K
    Rajvanshi, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (15): : 1630 - 1630
  • [7] Efficacy and safety of peginterferon alfa-2a in Chinese patients with HBeAg-positive chronic hepatitis B
    Xu, D. -Z.
    Xie, Y.
    Wei, L.
    Chen, X. Y.
    Wan, M. -B.
    Wang, Y. -M.
    Wang, L.
    Wei, J.
    Gan, J. -H.
    Tian, D. -Y.
    Zhang, S. -L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S266 - S266
  • [8] RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)
    Hou, J.
    Ma, H.
    Sun, J.
    Xie, Q.
    Xie, Y.
    Sun, Y.
    Wang, H.
    Shi, G.
    Wan, M.
    Niu, J.
    Ning, Q.
    Yu, Y.
    Xie, Y.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S432 - S433
  • [9] Characterization of Hepatitis B Surface Proteins in HBeAg-positive Patients with Chronic Hepatitis B (CHB) Treated With PegInterferon Alfa-2a (40KD)
    Rinker, Franziska
    Bremer, Corinna M.
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Glebe, Dieter
    Kraft, Anke R.
    Cornberg, Markus
    HEPATOLOGY, 2015, 62 : 1196A - 1197A
  • [10] A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B
    Chan, H. L. Y.
    Messinger, D.
    Papatheodoridis, G. V.
    Cornberg, M.
    Xie, Q.
    Piratvisuth, T.
    Ren, H.
    Kennedy, P. T.
    Thompson, A.
    Caputo, A.
    Bakalos, G.
    Pavlovic, V.
    Lampertico, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (05) : 547 - 555
12345